Previous Article | Next Article 
Molecular and Cellular Biology, July 2000, p. 4708-4723, Vol. 20, No. 13
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Cross Talk of pp125FAK and
pp59Lyn Non-Receptor Tyrosine Kinases to Insulin-Mimetic
Signaling in Adipocytes
Günter
Müller,*
Susanne
Wied, and
Wendelin
Frick
Aventis Pharma Deutschland GmbH, 65926 Frankfurt am Main, Germany
Received 31 January 2000/Returned for modification 20 March
2000/Accepted 12 April 2000
 |
ABSTRACT |
Signaling molecules downstream from the insulin receptor, such as
the insulin receptor substrate protein 1 (IRS-1), are also activated by
other receptor tyrosine kinases. Here we demonstrate that the
non-receptor tyrosine kinases, focal adhesion kinase pp125FAK and Src-class kinase pp59Lyn, after
insulin-independent activation by phosphoinositolglycans (PIG), can
cross talk to metabolic insulin signaling in rat and 3T3-L1 adipocytes.
Introduction by electroporation of neutralizing antibodies against
pp59Lyn and pp125FAK into isolated rat
adipocytes blocked IRS-1 tyrosine phosphorylation in response to PIG
but not insulin. Introduction of peptides encompassing either the major
autophosphorylation site of pp125FAK, tyrosine 397, or its
regulatory loop with the twin tyrosines 576 and 577 inhibited
PIG-induced IRS-1 tyrosine phosphorylation and glucose transport.
PIG-induced pp59Lyn kinase activation and
pp125FAK tyrosine phosphorylation were impaired by the
former and latter peptide, respectively. Up-regulation of
pp125FAK by integrin clustering diminished PIG-induced
IRS-1 tyrosine phosphorylation and glucose transport in nonadherent but
not adherent adipocytes. In conclusion, PIG induced IRS-1 tyrosine
phosphorylation by causing (integrin antagonized) recruitment of IRS-1
and pp59Lyn to the common signaling platform molecule
pp125FAK, where cross talk of PIG-like structures and
extracellular matrix proteins to metabolic insulin signaling may
converge, possibly for the integration of the demands of glucose
metabolism and cell architecture.
 |
INTRODUCTION |
Multiple downstream effectors of
insulin action are shared in common by many receptor tyrosine kinases.
This necessitates the existence of mechanisms for incorporating
specificity at each step in the insulin signal transduction pathway,
starting at the receptor and receptor substrate levels (16).
Integration of signals generated by the well-known cross talk of the
insulin receptor to different types of non-insulin receptor tyrosine
kinases (e.g., insulin-like growth factor 1 receptor [IGF-1R]) or
of the latter (e.g., platelet-derived growth factor receptor
[PDGF-R]) to the insulin receptor substrate (IRS) proteins may
contribute to the specificity of insulin action. Upon tyrosine
phosphorylation, IRS proteins provide a common interface for the
activated receptor and various downstream (Src homology 2 domain
[SH2] containing) signaling proteins, including
phosphatidylinositol-3'-kinase (PI 3K), p55PIK, Grb-2,
SHP2, Nck, and Crk (67, 71, 72).
Specificity of insulin action may also be determined by the external
environment of the cells mediated through signal cross talk from
integrins. Integrins, transmembrane proteins expressed in most tissues,
including insulin-sensitive adipose and muscle cells, bind to
particular extracellular matrix proteins. The key biological functions
of integrins, including cell migration and adhesion, are mediated in
part by focal adhesion kinase, pp125FAK (2, 8).
There is evidence that signaling pathways initiated by integrins
synergize functionally with those triggered by growth factors (32,
55). Recent data imply that insulin potently augments
5
1-integrin-mediated cell adhesion of
insulin receptor-expressing CHO cells, while signaling via this
integrin in turn enhances insulin receptor kinase activity and tyrosine
phosphorylation and formation of complexes containing IRS-1 and PI 3K
(15). The latter findings were extended to isolated rat
adipocytes for artificial clustering of
5
1-integrin (14). Thus, the
insulin receptor may act synergistically with integrins to enhance cell adhesion, and, vice versa, the extracellular matrix surrounding the
cell may influence signaling specificity by the insulin receptor.
A signaling pathway which also might sense information from the
cellular environment or extracellular proteins and cross talk to
various signal transduction cascades, such as insulin signaling, but is
less well understood than the integrin system, emerges from
glycosylphosphatidylinositol-anchored plasma membrane proteins (GPI
proteins). The protein moiety of GPI proteins is attached to the
extracellular face of the plasma membrane via a covalently attached
glycolipid of the glycosylphosphatidylinositol (GPI) type that is
embedded in the outer leaflet of the phospholipid bilayer
(42). Two modes of initiation of signaling events through GPI proteins have been described so far. (i) Cross-linking of certain
GPI proteins with antibodies in T cells and neutrophils elicits
cell-specific responses via activation of non-receptor tyrosine kinases
which are associated with the inner leaflet of the plasma membrane via
their fatty acyl chains and form together with GPI proteins so-called
glycolipid-enriched detergent-insoluble raft domains within the plasma
membrane (5, 51, 56, 58, 59). (ii) Lipolytic cleavage of the
GPI anchor of certain GPI proteins by a GPI-specific phospholipase C
induces a range of insulin-mimetic metabolic effects in
insulin-responsive cells (30, 35). The molecular
mechanism(s) for signal transmission from GPI proteins via the plasma
membrane to intracellular signaling cascades has not been elucidated
for either mode; however, it has been linked to the generation of
soluble phosphoinositolglycan (PIG) molecules in case of phospholipase
C action (64).
PIG molecules represent the polar core glycan head groups of free GPI
lipids or GPI protein membrane anchors. They consist of a cyclic
phosphoinositol moiety coupled to nonacetylated glucosamine and an
additional glycan structure, which in case of GPI protein membrane
anchors, is built from three mannose residues in typical glycosidic
linkages followed by a phosphodiester bridge to the terminal
ethanolamine residue (20, 34, 36). During the past few
years, we have demonstrated that chemically synthesized complete PIG
molecules (Fig. 1) mimic a number of
metabolic insulin effects (e.g., stimulation of glucose transport and
nonoxidative glucose metabolism) in normal and insulin-resistant
isolated fat and muscle cells at the micromolar range to up to the
maximal insulin response (11). The complete glycan core
structure (three mannose residues plus glucosamine) of typical GPI
protein membrane anchors including a mannose side chain and the
inositol(cyclic)phosphate moiety (Fig. 1) is required for maximal
insulin-mimetic activity of PIG compounds, with some variations
possible with regard to the type of residues coupled to the terminal
mannose or inositol as well as the type of linkages involved
(12). This potent insulin-mimetic metabolic activity of PIG
compounds is not accompanied by stimulation of the insulin receptor
tyrosine kinase; however, it correlates with dramatic tyrosine
phosphorylation of IRS-1 as well as activation of PI 3K and its
downstream-located cascade (12, 22, 39, 40). Thus, PIG
compounds seem to mimic metabolic insulin action by insulin
receptor-independent activation of the IRS-PI 3K pathway and thus
circumvent defects at the level of the insulin receptor in muscle and
adipose tissue (Fig. 1), which may represent (in part) the molecular
basis for peripheral insulin resistance, the hallmark of
non-insulin-dependent diabetes mellitus (28).

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 1.
Structure of the PIG compounds 1, 7, 37, and 41 (with
the activity-determining phosphate moiety marked by an asterisk) and
their mode of action in fat and muscle cells according to references
12 and 22 (also see the
introduction). PIG compounds induce tyrosine phosphorylation of IRS
proteins and their association with PI 3K, which is thereby activated,
as does insulin by stimulating the insulin receptor tyrosine kinase.
Operation of the IRS-1-PI 3K pathway (and possibly membrane
association of the regulatory p85 subunit of PI 3K) is a prerequisite
for fusion of GLUT4-containing vesicles with the plasma membrane, the
so-called GLUT4 translocation, but may not be sufficient (also see
Discussion). In addition, PIG compounds modulate the phosphorylation
state of a number of phosphoproteins, which are not affected by insulin
(22), but may be required for PIG-dependent GLUT4
translocation.
|
|
The present study was performed to identify the tyrosine kinase(s)
responsible for PIG-dependent IRS phosphorylation and to characterize
the upstream-located signaling cascade. We found that insulin-mimetic
signaling by PIG compounds depends on activation and direct interaction
of the pp59Lyn and pp125FAK non-receptor
tyrosine kinases, which is antagonized by integrin engagement. This
raises the possibility for cross talk of a GPI protein-mediated signal
transduction cascade to metabolic insulin signaling via components of
the cell adhesion pathway.
 |
MATERIALS AND METHODS |
Materials.
[
-32P]ATP (6,000 Ci/mmol) and
2-deoxy-D-[2,6-3H]glucose (60 Ci/mmol) were
bought from NEN/DuPont (Bad Homburg, Germany). PIG 41, 37, 45, 7, and 1 and recombinant human insulin were made available by the Departments of
Medicinal Chemistry and Pharma Synthesis of Aventis Pharma (Frankfurt
am Main, Germany). Recombinant human IRS-1 was delivered by Upstate
Biotechnology (Lake Placid, N.Y.). pp125FAK (amino acids
[aa] 385 to 405) Src docking site wild-type (Y397) peptide and mutant
(F397) control peptide and pp125FAK (aa 368 to 388) control
peptide, pp125FAK (aa 568 to 582) regulatory loop wild-type
(Y576, Y577) peptide and mutant (F576, F577) control peptide, GRGDSP
peptide, and GRADSP peptide were synthesized by Biotrend (Cologne,
Germany). Human plasma fibronectin, rat plasma vitronectin, and
poly-L-lysine were purchased from Sigma (Deisenhofen,
Germany). Neutralizing anti-pp59Lyn and
anti-pp125FAK antibodies were prepared in our laboratory by
immunizing rabbits with the recombinant (insect cells) catalytic SH1 of
human pp59Lyn comprising aa 217 to 512 and catalytic domain
of chicken pp125FAK comprising aa 354 to 625, respectively,
fused to amino-terminal glutathione S-transferase tags.
Monoclonal antibodies against pp59Lyn (clone 42), paxillin
(clone 165), and pp125FAK (clone 77) for
immunoprecipitation were obtained from Transduction Laboratories
(Lexington, Ky.). Monoclonal antiphosphotyrosine antibody (clone 4G10)
for immunoblotting was purchased from Upstate Biotechnology. Anti-IRS-1
antibody for immunoprecipitation raised in rabbits against total human
recombinant (insect cells) IRS-1 (purified by gel filtration) was
provided by Biotrend. Anti-IRS-1 antibody for immunoblotting raised in
rabbits against a synthetic peptide corresponding to the
carboxy-terminal sequence comprising aa 1223 to 1235 of rat IRS-1 was a
kind gift of Suzanne Dalle (Humboldt University, Berlin, Germany).
Monoclonal anti-
1-integrin antibody (clone K20) for
clustering was bought from Immunotech (San Francisco, Calif.).
Monoclonal anti-
3-integrin antibody for clustering
(clone F11) was delivered by PharMingen (Heidelberg, Germany).
Polyclonal antirat immunoglobulin G (IgG) (whole molecule) from rabbit
(used as nonimmune IgG) was bought from Sigma (Deisenhofen, Germany).
Materials for cell culture (including sera) were obtained from
Gibco/BRL (Eggenstein/Leopoldshafen, Germany). Antibiotics and
proteinase inhibitors were from Roche Molecular Biochemicals (Mannheim,
Germany). Detergents were bought from Calbiochem (Bad Soden, Germany).
All other chemicals were provided by Merck (Darmstadt, Germany) unless
indicated otherwise.
Preparation and stimulation of isolated rat adipocytes with
insulin or PIG.
Adipocytes from epididymal fat pads of male Wistar
rats prepared as described previously (39) were suspended in
buffer S [Dulbecco's minimal essential medium (DMEM) containing 5 mM
glucose, 0.5 mM sodium pyruvate, 4 mM L-glutamine, 200 nM
1-methyl-2-(phenylethyl)adenosine (PIA), 100 µg of gentamicin per ml,
1% bovine serum albumin (BSA), and 25 mM HEPES-KOH (pH 7.4)] at 5%
cytocrit (corresponding to about 7 × 105 cells/ml).
For determination of the packed cell volume, small aliquots of the cell
suspension were aspirated into capillary hematocrit tubes and
centrifuged for 90 s in a microhematocrit centrifuge in order to
measure the fractional occupation of the suspension by the adipocytes
(cytocrit). A 20-ml portion of the (electroporated) adipocyte
suspension (5% cytocrit) was added to 20 ml of buffer S containing PIG
or human insulin as indicated. Incubations (20 min, 37°C) were
performed under 5% CO2 in 200-ml polyethylene vials with
shaking at 110 cycles/min and with a stroke length of 3.5 cm.
Preparation and stimulation of adherent 3T3-L1 adipocytes with
insulin or PIG.
3T3-L1 fibroblasts were seeded in 12-well (60,000 cells/well) plates and maintained in DMEM (high glucose) plus 10%
fetal bovine serum (FBS), 5 mM L-glutamine, and 2% BSA.
Following 3 days at 100% confluence, differentiation was initiated by
the addition of DMEM containing 10% FBS, 400 nM human insulin, 1 µM dexamethasone, and 1 mM isobutylmethylxanthine (Sigma, Deisenhofen, Germany). Three days later, the medium was replaced with DMEM plus 10%
FBS and 100 nM insulin. After an additional 2 days, the medium was
changed to DMEM (low glucose) plus 10% FBS. Adipocytes were used 5 to
12 days after completion of the differentiation protocol, when more
than 85% of the cells expressed the adipocyte phenotype. Prior to
experiments, the cells were rinsed two times with low serum medium
(DMEM containing 5 mM glucose, 0.5% BSA, 0.1% FBS, 25 mM HEPES [pH
7.4] 10 mM glutamine, 100 U of streptomycin or penicillin per ml) and
then incubated (12 to 14 h) in this medium and finally washed
twice with phosphate-buffered saline (PBS) containing 2 mM sodium
pyruvate prior to incubation (30 min, 37°C) with PIG or insulin as
indicated in 4 ml of buffer S.
Preparation and stimulation of nonadherent 3T3-L1 adipocytes with
insulin or PIG.
Adherent 3T3-L1 adipocytes were serum starved for
12 h in a mixture of serum-free DMEM, 10 mM glutamine, 0.5% BSA,
and 50 U of streptomycin or penicillin per ml; thereafter washed twice with PBS containing 1 mM EDTA; and then removed gently from the dishes
by using a rubber policeman. After being washed once in PBS, the cells
were maintained in suspension (30 min, 37°C) in 4 ml of PBS
containing 5 mM glucose, 1% BSA, and 200 nM PIA before the addition of
PIG or insulin as indicated and further incubation (30 min, 37°C).
Attachment of 3T3-L1 adipocytes to fibronectin-coated
dishes.
Cell culture dishes (12-well plates) were coated (4°C,
overnight) with fibronectin (10 µg/ml) or poly-L-lysine
(10 µg/ml) together with vitronectin (2 µg/ml) in PBS containing
2.7 mM KCl, 6.5 mM Na2HPO4, and 1.5 mM
KH2PO4 (pH 7.4), blocked (1 h) with 0.1% BSA
in PBS, and then dried (1 h, 37°C) prior to plating of the cells.
Confluent 3T3-L1 adipocytes were serum starved for 12 h in
serum-free DMEM, 10 mM glutamine, 0.5% BSA, and 50 U of streptomycin-penicillin per ml and then detached by adding EDTA-trypsin (0.05 mM, 0.025%). The detached adipocytes were washed three times with PBS containing 1% BSA and then held in suspension (30 min, 37°C) in 4 ml of buffer S prior to addition of PIG or insulin as
indicated. After incubation (10 min, 37°C), the cells were replated
on dishes coated with fibronectin or poly-L-lysine in the
absence or presence of 25 µg of peptide per ml as indicated and
further incubated (20 min, 37°C) under 5% CO2.
Electroporation of isolated rat adipocytes.
A 0.4-ml portion
of buffer E (4.74 mM NaCl, 118 mM KCl, 0.38 mM CaCl2, 1 mM
EGTA, 1.19 mM MgSO4, 1.19 mM
KH2PO4, 25 mg of BSA per ml, 3 mM sodium
pyruvate, 25 mM HEPES-KOH, pH 7.4) was placed in a 0.4-cm gap-width
electroporation cuvette (Bio-Rad, Munich, Germany) together with the
antibodies or peptides. A 0.4-ml portion of the adipocyte suspension
(50% cytocrit in buffer E) was added to each cuvette and gently mixed.
Electroporation was performed with a Gene Pulser Transfection Apparatus
(Bio-Rad), which was set at a capacitance of 25 µF and voltage of 800 V (2 kV/cm), at 25°C for six shocks (46, 57). After the
third treatment, the adipocyte suspension was gently stirred with a
plastic stick, and the electric polarity was reversed. The time
constant of electroporation was typically 0.6 ms during the final
shock. Routinely, 4 ml of adipocyte suspension (25% cytocrit) was
electroporated in five cuvettes. The time required for treatment of the
five cuvettes was about 3 min. After electroporation, the cells from
five electroporations were pooled and transferred to 50-ml polystyrene
tubes (Falcon). After incubation (30 min, 37°C) in 5%
CO2-95% O2, the cells were centrifuged
(200 × g, 1 min, swing-out rotor) and the infranatant was aspirated. Thereafter the cells were washed once with 40 ml of
buffer S containing 4% BSA, suspended in 20 ml of buffer S, and then
incubated (1 h, 37°C) under 5% CO2 prior to stimulation with PIG or insulin (see above).
Clustering of adipocytes.
Isolated rat adipocytes or
nonadherent 3T3-L1 adipocytes were washed with buffer S containing 2%
BSA and 2 mM pyruvate and then suspended in the same medium at 10%
cytocrit. After 30 min of rest, the cells were incubated (30 min,
37°C) in the absence or presence of anti-
1-integrin or
anti-
3-integrin antibody (4 µg/ml) together with
plasma human fibronectin or poly-L-lysine (40 µg/ml) with
or without further additions and then stimulated (20 min, 37°C) with
PIG as indicated under 5% CO2.
Preparation of cell lysates.
Stimulated adherent or
nonadherent 3T3-L1 cells were placed on ice and then washed twice with
a mixture of 50 mM HEPES-KOH (pH 7.5), 150 mM NaCl, 1 mM
CaCl2, 1 mM MgCl2, 10 mM EDTA, 10 mM
glycerol-3-phosphate, 10 mM
Na4P2O7, 2 mM
Na3VO4, 100 mM NaF (in the case of nonadherent
cells by flotation [200 × g, 2 min] and aspiration
of the infranatant). Cells were solubilized in the above buffer
containing 1% (vol/vol) Triton X-100, 0.1% sodium deoxycholate, 10%
glycerol and protease inhibitors (20-µg/ml leupeptin, 10-µg/ml
pepstatin A, 50-µg/ml aprotinin, 10 µM E-64, 0.5 mM
phenylmethylsulfonylfluoride [PMSF] [lysis buffer]) for 30 min on
ice (nonadherent cells) or by scraping with a Teflon policeman
(adherent cells). Total lysates were centrifuged (25,000 × g, 20 min, 18°C). The infranatant was aspirated, taking care to
avoid contamination by the upper fat layer, and recentrifuged to obtain
the defatted cell lysate. Stimulated normal or electroporated rat
adipocytes were washed once with PBS containing 2 mM sodium pyruvate by
flotation (200 × g, 2 min) and aspiration of the
infranatant and immediately homogenized in lysis buffer containing 4 mM
benzamidine by 10 strokes/200 rpm in a medium-fitting Teflon-in-glass
homogenizator (2-ml vessel volume) at 18°C. Defatted cell lysate was
prepared as described above.
Immunoprecipitation.
Defatted cell lysates (standardized for
5 to 10 µg of protein) were precleared (1 h, 4°C) with protein G or
A-Sepharose (Pharmacia, Freiburg, Germany) and then supplemented with
the appropriate antibodies (pp125FAK, 2 µg/sample; IRS-1,
1:50 serum dilution; pp59Lyn, 5 µg/sample; paxillin, 0.7 µg/sample) preadsorbed on protein G-Sepharose (monoclonal antibodies)
or protein A-Sepharose (rabbit antibodies) in a total volume of 100 µl of lysis buffer. After incubation (4 h, 4°C, end-over-end
rotation) and centrifugation (13,000 × g, 2 min,
4°C), the collected immune complexes were washed twice with 1 ml each
of immunoprecipitation buffer (50 mM HEPES-KOH [pH 7.4], 500 mM NaCl,
100 mM NaF, 10 mM EDTA, 10 mM
Na4P2O7, 1 mM
Na3VO4) containing 1% NP-40 (omitted for
sequential immunoprecipitation), and then twice with 1 ml each of
immunoprecipitation buffer containing 150 mM NaCl and 0.1% NP-40 and
once with 1 ml of immunoprecipitation buffer lacking salt and detergent
and finally suspended in 50 µl of Laemmli buffer (2% sodium dodecyl
sulfate [SDS], 5% 2-mercaptoethanol), heated (95°C, 2 min), and
centrifuged. The supernatant samples were analyzed by
SDS-polyacrylamide gel electrophoresis (PAGE; 4 to 12% Bis-Tris
precast gel [pH 6.4], morpholinoethanesulfonic acid [MES]-SDS
running buffer; Novex, San Diego, Calif.) under reducing conditions.
For sequential immunoprecipitation, the supernatant samples (50 µl)
were supplemented with 1 ml of immunoprecipitation buffer containing
1% NP-40 and 5 µl of anti-IRS-1 antiserum. After incubation (12 h,
4°C), 50 µl of protein A-Sepharose (100 mg/ml in
immunoprecipitation buffer) was added, and the incubation continued (4 h, end-over-end rotation). The immune complexes were collected, washed,
and processed for SDS-PAGE as described above.
Immunoblotting.
Proteins were transferred to polyvinylidene
difluoride membranes (Immobilon; Millipore, Eschborn, Germany). The
blocked membrane was incubated (2 h, 25°C) with antibodies against
pp125FAK (1:200), IRS-1 (1:500), or phosphotyrosine (2 µg/ml), washed (four times with Tris-buffered saline [TBS]
containing 1% [vol/vol] NP-40 and 0.5% Tween 20, twice with TBS
containing 0.5% Tween 20, and twice with TBS) and then incubated (1 h,
25°C) with the appropriate horseradish peroxidase-coupled detection
(antimouse or antirabbit) antibodies (1:15,000 dilution; enhanced
luminescence; Pierce, Rockford, Ill.) in TBS containing 5% (wt/vol)
BSA, washed (five times with TBS containing 1% NP-40 and 0.5% Tween
20, three times with TBS containing 0.05% Tween 20), and finally
processed with chemiluminescent reagents (Renaissance Chemiluminescence Detection System; NEN/DuPont, Bad Homburg, Germany) and subjected to phosphorimaging.
Immune complex kinase assays.
pp59Lyn or
pp125FAK immune complexes were washed in kinase buffer (50 mM HEPES-KOH [pH 7.4], 100 mM NaCl, 5 mM MnCl2, 1 mM
MgCl2, 0.5 mM dithiothreitol [DTT], 1 mM
Na3VO4), and then suspended in 50 µl of
kinase buffer. The kinase reactions were started by addition of ATP
(unlabeled or 32P-labeled; final concentrations:
pp59Lyn, 40 µM; 0.2 mCi/ml; pp125FAK, 100 µM, 0.5 mCi/ml) and incubated (pp59Lyn, 15 min;
pp125FAK, 3 min [22°C]) in the absence
(autophosphorylation) or presence of recombinant human IRS-1 (0.3 µg)
or heat-denatured (10 min, boiling waterbath) rabbit muscle enolase (1 µg; Sigma, Deisenhofen, Germany). Autophosphorylation reactions were
terminated by addition of 50 µl of ice-cold stop buffer (50 mM
HEPES-KOH [pH 7.4], 150 mM NaCl, 100 mM ATP, 0.05% Triton X-100) and
washing of the beads twice with 1 ml of stop buffer prior to addition
of 20 µl of Laemmli buffer and boiling (95°C, 5 min). Substrate
phosphorylation reactions were terminated by addition of 10 µl of
fourfold-concentrated Laemmli buffer and boiling. The
phosphoproteins were separated by SDS-PAGE (10% Bis-Tris resolving
gel, MES-SDS running buffer) and analyzed by phosphorimaging directly
(use of [32P]ATP) or after immunoblotting with
antiphosphotyrosine antibody (use of unlabeled ATP). Under these
conditions, the kinase reactions were linear with time for the assay period.
Glucose transport.
Glucose transport was assayed after two
washing cycles of the cells with glucose-free and serum-free DMEM by
using 2-deoxy-D-[2,6-3H]glucose (50 µM,
0.33 µCi/ml; 20 min at 37°C) in the absence or presence of 20 µM
cytochalasin B for isolated rat adipocytes and nonadherent 3T3-L1
adipocytes by using the oil-centrifugation method (39) and
for adherent 3T3-L1 adipocytes by washing the cells twice with ice-cold
PBS containing 5 mM D-glucose and subsequent addition of
0.2% SDS-0.1 N NaOH prior to liquid scintillation counting
(61).
Miscellaneous.
Protein concentration was determined by the
bicinchoninic acid protein assay protocol from Pierce (Rockford, Ill.)
with crystalline BSA as a standard. Phosphorimaging was performed with
a Storm 860 PhosphorImager (Molecular Dynamics) and quantitatively
evaluated with ImageQuant software (Molecular Dynamics). Differences in recovery in the amounts of immunoprecipitated protein during a specific
experiment were corrected in each case (data on fold or percent
stimulation) for the amount of protein actually applied to the gel by
homologous immunoblotting. All of the results reported herein were
confirmed by running independent experiments with different batches of
adipocytes several times (as indicated in the figure legends), each
with two to five parallel independent immunoprecipitation, kinase
assay, and immunoblotting analyses.
 |
RESULTS |
Involvement of pp59Lyn in insulin-mimetic signaling by
PIG in adipocytes.
Our previous studies unequivocally have
demonstrated that insulin-mimetic signaling by PIG critically depends
on insulin receptor-independent tyrosine phosphorylation of IRS-1, -2, and -3 (39, 40). Differential sensitivity of insulin and PIG
stimulation of lipogenesis toward tyrosine kinase inhibitors
(11) and the reported association of members of Src-class
kinases with GPI proteins (see Introduction) led us to speculate on the
involvement of non-receptor rather than receptor tyrosine kinases in
PIG signaling (34). Furthermore, Lebrun and coworkers found
that expression of a constitutive active pp60Src in 293 EBNA cells results in strong IRS-1 tyrosine phosphorylation (27). In addition, during an effort to identify new IRS-1
binding proteins by screening a mouse embryo expression library with
recombinant [32P]IRS-1, a specific association between
IRS-1 and pp60Fyn via its SH2 domain and Tyr895
and Tyr1172 of IRS-1 was detected (60). These
results suggested a role for Src-class kinases during insulin
signaling. pp59Lyn kinase is the predominant Src-class
kinase in isolated rat adipocytes (47) and was therefore
selected as a candidate non-insulin receptor tyrosine kinase for
PIG-dependent IRS phosphorylation.
We studied the participation of pp59
Lyn in PIG signaling by
using a polyclonal antibody raised against its kinase domain. The
concentration-dependent inhibition of pp59
Lyn activity by
this antibody was demonstrated in an immune complex
kinase assay with
pp59
Lyn immunoprecipitated from rat adipocytes (Table
1). A 1:50 dilution
of the serum blocked
more than 80% of pp59
Lyn autophosphorylation as well as
enolase and IRS-1 phosphorylation
compared to an unrelated antibody.
The anti-pp59
Lyn antibodies used for neutralization as well
as immunoprecipitation
were highly specific, since they did not inhibit
and precipitate
(according to activity and protein, respectively), the
closely
related Src kinase family members pp60
Fyn and
pp60
Src to any significant extent in in vitro kinase assays
using the
recombinant proteins (Table
2).
The neutralizing antibody was
introduced into isolated rat adipocytes
by electroporation with
high efficiency as shown by analysis of
pp59
Lyn autophosphorylation in the basal or
insulin-stimulated state
(Table
3). Basal
and insulin-induced tyrosine phosphorylation
of pp59
Lyn
were diminished during the 15-min incubation period in a serum
concentration-dependent manner by up to 50 and 75%, respectively,
compared to unrelated control antibody. The tyrosine phosphorylation
left may be due to extrinsic pp59
Lyn phosphorylating
enzyme(s). A 1:25 dilution of the neutralizing
antibody was used for
analysis of IRS-1 tyrosine phosphorylation
in electroporated rat
adipocytes following incubation with increasing
concentrations of PIG
41 or human insulin. Stimulation of IRS-1
tyrosine phosphorylation by
PIG 41 was significantly impaired
compared to that of the control
antibody with regard to both maximal
responsiveness (from 19.3- to
9.7-fold) and sensitivity (Fig.
2). In
contrast, basal and insulin-dependent IRS-1 tyrosine phosphorylations
were not significantly affected. These data represented a first
indication that pp59
Lyn mediates (directly or indirectly)
PIG-induced, but not insulin-induced
and basal, tyrosine
phosphorylation of IRS-1.

View larger version (62K):
[in this window]
[in a new window]
|
FIG. 2.
Effect of anti-pp59Lyn antibody on
PIG-induced IRS-1 tyrosine phosphorylation in adipocytes. Isolated rat
adipocytes were electroporated with nonimmune IgG or neutralizing
anti-pp59Lyn antibody (1:25) and then incubated in the
absence or presence of increasing concentrations of PIG 41 or human
insulin. IRS-1 was immunoprecipitated (IP) with anti-IRS-1 antibody
from defatted cell lysates and then immunoblotted (IB) with
antiphosphotyrosine antibody. Phosphorimages of a typical experiment
are shown (left section) repeated four times with similar results.
Quantitative evaluation is given as fold stimulation (mean ± standard deviation [right section]). Basal tyrosine phosphorylation
is set at 1 in each case.
|
|
We next studied with an immune complex kinase assay whether PIG
compounds (of various structures and potencies) manage to
activate
pp59
Lyn kinase in rat adipocytes. PIG 41 induced
pp59
Lyn autophosphorylation in a concentration-dependent
fashion (at
concentrations effective in stimulating glucose metabolism
in
adipocytes [
12]) to up to 13.2-fold with effective
concentrations
for half-maximal activation (EC
50) of 0.24 µM. PIG 37 and 7 were
significantly less potent, whereas PIG 1 was
virtually inactive.
The PIG-induced increase in pp59
Lyn
tyrosine phosphorylation was reduced by the neutralizing
anti-pp59
Lyn antibody in a concentration-dependent fashion
by up to 75% compared
to an unrelated antibody (Table
3), which
correlated well with
the anti-pp59
Lyn antibody-mediated
blockade of IRS-1 tyrosine phosphorylation
in response to PIG 41 (Fig.
2). Interestingly, insulin also caused
considerable activation of
pp59
Lyn, although to a much lower degree (3.7-fold at 3 nM;
Fig.
3A).
The PIG- or insulin-induced
autophosphorylation of pp59
Lyn in rat adipocytes was
accompanied by increased IRS-1 tyrosine
phosphorylation
irrespective of whether incorporation of radiolabeled
phosphate
into IRS-1 or antiphosphotyrosine immunoreactivity of
IRS-1 was
followed (Fig.
3B). The levels of effectiveness of the
four PIG
compounds with regard to both maximal responsiveness
(fold-stimulation)
and sensitivity (EC
50) were similar for auto-
and IRS-1
phosphorylation. The rankings of these PIG compounds
in causing
pp59
Lyn and glucose transport activation in rat adipocytes
are identical
(
12).

View larger version (83K):
[in this window]
[in a new window]
|
FIG. 3.
Effect of PIG compounds on pp59Lyn activity.
Isolated rat adipocytes were incubated in the absence or presence of
increasing concentrations of PIG compounds or human insulin.
pp59Lyn was immunoprecipitated (IP) with
anti-pp59Lyn antibody from defatted cell lysates and then
subjected to immune complex kinase assays for autophosphorylation by
incubation with unlabeled ATP (A) or phosphorylation of recombinant
human IRS-1 by incubation with either [32P]ATP or
unlabeled ATP (B). Phosphorimages of a typical experiment are shown
(left sections) repeated three times with similar results. Basal
pp59Lyn autophosphorylation and IRS-1 tyrosine
phosphorylation were rather low and comparable to those observed in the
presence of up to 0.01 µM PIG 37, 7, and 1 (which are shown instead
of the basal phosphorylations only). Quantitative evaluation is given
as fold stimulation (mean ± standard deviation [right
sections]). Basal phosphorylation is set at 1 in each case. Insulin
increased autophosphorylation of pp59Lyn and tyrosine
phosphorylation of IRS-1 (according to antiphosphotyrosine
immunoblotting [IB]), respectively, 1.6- to 1.4-fold at 0.3 nM, 2.2- to 2.7-fold at 1 nM, and 3.1- to 2.9-fold at 3 nM versus the basal
level.
|
|
Involvement of pp125FAK in insulin-mimetic signaling
and action by PIG in adipocytes.
In many cell types, Src-class
kinase family members are activated by the cytosolic focal adhesion
kinase, pp125FAK, which is involved in integrin signaling,
cytoskeletal reorganization, and signal transduction by a number of
growth factors (13, 48, 76). Recently it was found that in
nonattached cells, insulin promotes pp125FAK
phosphorylation and activation and pp125FAK is a direct
substrate of the insulin receptor tyrosine kinase (3).
Furthermore, the interaction of IRS-1 with pp125FAK using a
mammalian two-hybrid system or coimmunoprecipitation and extensive
IRS-1 tyrosine phosphorylation upon expression of pp125FAK
in 293 EBNA cells were described (27).
Therefore, we studied the effect of neutralizing
anti-pp125
FAK antibody on PIG-dependent tyrosine
phosphorylation and glucose
transport activation. The inhibitory
activity of this antibody
was verified in an immune complex kinase
assay with the substrate
paxillin, the tyrosine phosphorylation of
which was reduced by
70% (Table
4). The
specificity of the anti-pp125
FAK antibodies used for
neutralization as well as immunoprecipitation
(in subsequent
experiments [see below]) was demonstrated by the
very modest
inhibition and precipitation, respectively, of the
closely related
pp116
PYK2 kinase and by their complete failure to do this
with different
members of the Src kinase family (Table
2). Introduction
of this
antibody into isolated rat adipocytes by electroporation
led to
an almost 50% reduction (compared to a nonrelated control IgG)
in PIG 41-induced tyrosine phosphorylation of pp125
FAK and
one of its substrates, the cytoskeletal protein paxillin
(
4,
6,
53,
62). This was nicely correlated with inhibition
of IRS-1
tyrosine phosphorylation and glucose transport upregulation
in
response to PIG 41 (Table
4). In contrast, basal and insulin-dependent
IRS-1 tyrosine phosphorylation and glucose transport activation
were
not significantly affected by the anti-pp125
FAK antibody,
although it reduced pp125
FAK and paxillin tyrosine
phosphorylation in response to insulin
up to 50% (Table
4). Thus,
pp125
FAK is also involved (directly or indirectly) in
PIG-triggered tyrosine
phosphorylation of IRS-1 and downstream
signaling to the glucose
transport system, but does not contribute
significantly to the
corresponding insulin actions and basal states.
Incubation of isolated rat adipocytes with increasing concentrations of
PIG compounds (Fig.
4A, left section)
revealed significant
increases in tyrosine phosphorylation of
immunoprecipitated pp125
FAK and paxillin in response to PIG
41 (to up to 7.9- and 11.5-fold,
respectively, at 3 µM), PIG 37 (to
up to 4.3- and 9.8-fold, respectively,
at 3 µM), and PIG 7 (to up to
2.5- and 4.3-fold, respectively,
at 3 µM [not shown in Fig.
4A]).
Furthermore, PIG 41 increased
the amount of IRS-1 coimmunoprecipitated
with pp125
FAK from PIG 41-treated adipocytes in a
concentration-dependent fashion
to up to 9.5-fold at 1 µM (corrected
for different recovery of
pp125
FAK by homologous
immunoblotting, Fig.
4A, right section). Tyrosine
phosphorylation of
pp125
FAK and paxillin in response to PIG 1 was very modest
(to up to 1.6-
and 2.9-fold, respectively, at 3 µM; Fig.
4A, left
section) and
apparently resulted in a weak association of
pp125
FAK with IRS-1 only (to up to 2.6-fold at 3 µM; Fig.
4A, right section).
The relative rankings of the various PIG compounds
with regard
to activation of pp125
FAK and
pp59
Lyn parallel one another and that for IRS-1 tyrosine
phosphorylation.
The combined data argue for (direct or indirect)
involvement of
these two kinases in PIG-induced IRS tyrosine
phosphorylation.

View larger version (70K):
[in this window]
[in a new window]
|
FIG. 4.
Effect of PIG compounds on tyrosine phosphorylation of
pp125FAK and paxillin and pp125FAK-IRS-1
association. Isolated rat adipocytes (A) or nonadherent and adherent
3T3-L1 adipocytes (B) were incubated in the absence or presence of
increasing concentrations of PIG compounds. pp125FAK and
paxillin were immunoprecipitated (IP) with corresponding antibodies
from defatted cell lysates and immunoblotted (IB) with anti-IRS-1,
anti-pp125FAK (pp125FAK only), or
antiphosphotyrosine antibodies. Phosphorimages of typical experiments
are shown (A) repeated two to four times with similar results.
Quantitative evaluation is given as fold stimulation (mean ± standard deviation [B]). Basal tyrosine phosphorylation and
association are set at 1 in each case.
|
|
pp125
FAK is localized at focal adhesion plaques of cultured
cells and binds to a number of proteins involved in the organization
of
the cytoskeleton (e.g., paxillin) and to signaling molecules,
resulting
in the formation of multicomponent complexes which cooperate
in both
the adhesion-mediated and growth-factor-mediated signaling
pathways and
finally initiate anchorage-dependent growth (
23,
63,
76).
Interestingly, pp125
FAK as a point of convergence for both
pathways has been demonstrated
in Rat-1 embryo fibroblasts
overexpressing the insulin receptor
and Hep-G2 hepatocytes upon insulin
challenge to be dephosphorylated
in the adherent cells but
phosphorylated in nonadherent cells
(
3,
24,
44). These data
prompted us to investigate the
influence of the cell architecture on
phosphorylation and activation
of pp125
FAK in cultured
3T3-L1 adipocytes which have been incubated with
increasing
concentrations of PIG 41 in either an adherent or nonadherent
state
(see Materials and Methods). Tyrosine phosphorylation of
immunoprecipitated pp125
FAK and paxillin and
coimmunoprecipitation of IRS-1 with pp125
FAK in response to
PIG 41 was significantly elevated in nonadherent
3T3-L1 adipocytes in
suspension and roughly comparable to that
observed with isolated rat
adipocytes (Fig.
4B) compared to cells
adherent on culture dishes. The
maximal responses were reduced
by 55% for pp125
FAK
tyrosine phosphorylation, 35% for paxillin tyrosine phosphorylation,
and 50% for pp125
FAK-IRS-1 association in adherent versus
nonadherent 3T3-L1 adipocytes
(Fig.
4B). Next we studied whether
nonadherent 3T3-L1 adipocytes
loose their responsiveness to PIG upon
readhesion to (fibronectin
coated) culture dishes. Inhibition of
adhesion of the detached
3T3-L1 adipocytes to fibronectin-coated dishes
in the presence
of excess RGD motif-containing peptide, GRGDSP, which
specifically
interferes with the integrin-fibronectin interaction, led
to almost
full maintenance of the maximal PIG response and sensitivity
of
tyrosine phosphorylation of pp125
FAK, paxillin, and
IRS-1 (Fig.
5). In contrast, readhesion
of the
3T3-L1 adipocytes to fibronectin-coated dishes in the presence
of the nonfunctional GRADSP peptide (which fails to bind to integrins)
caused a 40 to 60% reduction in PIG action. Thus, cell adhesion
(presumably via the integrin-fibronectin interaction) apparently
interferes with PIG-induced pp125
FAK activation and
downstream signaling in 3T3-L1 adipocytes.

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 5.
Effect of cell attachment on PIG-induced tyrosine
phosphorylation of pp125FAK, paxillin and IRS-1, and
pp125FAK and IRS-1 association. Serum-starved adherent
3T3-L1 adipocytes were detached, held in suspension (30 min), and then
stimulated (10 min) in the absence or presence of increasing
concentrations of PIG 41, replated on fibronectin-coated culture dishes
in the absence or presence of 0.5 mM GRGDSP or GRADSP peptide, and
further incubated (20 min). pp125FAK, paxillin, and IRS-1
were immunoprecipitated (IP) with corresponding antibodies from
defatted cell lysates and then immunoblotted (IB) with
antiphosphotyrosine or anti-IRS-1 antibodies (pp125FAK
only). Phosphorimages of three to four independent experiments were
quantitatively evaluated as fold stimulation (mean ± standard
deviation). Basal tyrosine phosphorylation and association are set at 1 in each case.
|
|
Interaction of pp125FAK and pp59Lyn in
insulin-mimetic signaling and action in adipocytes.
It is
generally assumed that pp125FAK activates Src-class kinases
by docking of the phosphorylated tyrosine 397 of pp125FAK
to the SH2 domain of the Src-class kinase, thereby preventing its
carboxy-terminal phosphotyrosine residue from binding to the SH2
domain, which is assumed to keep the kinase in the inactive state
(10, 47, 52). The involvement of pp125FAK on
pp59Lyn regulation during PIG signaling was studied by
electroporation of rat adipocytes with excess of functional Src docking
site peptide (encompassing residues 385 to 405, including Y397 from the
amino acid sequence of human pp125FAK) or nonfunctional Src
docking site peptide (with F397 replacing Y397) or an unrelated peptide
(encompassing residues 368 to 388 from pp125FAK) prior to
treatment with PIG 41 (Fig. 6). The
immune complex kinase assay with pp59Lyn revealed that the
Src docking site peptide Y397 diminished PIG 41-induced tyrosine
phosphorylation of pp59Lyn, IRS-1, and enolase to 15 to
45% of that observed with the mutant peptide F397 or the unrelated
peptide. Substrate phosphorylation by pp59Lyn was more
susceptible to inhibition by the Src docking site peptide Y397 than
autophosphorylation (Fig. 6). In conclusion, the functional Src docking
site peptide functions as a potent inhibitor for pp59Lyn
activation by PIG, most likely by preventing the interaction between
pp125FAK and pp59Lyn.

View larger version (50K):
[in this window]
[in a new window]
|
FIG. 6.
Effect of pp125FAK-Src docking site peptide
on PIG-induced activation of pp59Lyn. Isolated rat
adipocytes were electroporated with control peptide, mutant Src docking
site peptide F397, or wild-type Src docking site peptide Y397 (25 µg/ml) and then incubated in the absence or presence of increasing
concentrations of PIG 41. pp59Lyn was immunoprecipitated
(IP) with anti-pp59Lyn antibody from defatted cell lysates
and then subjected to an immune complex kinase assay for
autophosphorylation (by incubation with [32P]ATP and
subsequent SDS-PAGE of the total incubation mixture) or substrate
phosphorylation (by incubation with unlabeled ATP and either enolase or
recombinant IRS-1 and subsequent immunoblotting of the total incubation
mixture with antiphosphotyrosine antibody). Phosphorimages of a typical
experiment are shown (for pp59Lyn and IRS-1 [left
section]) repeated three times with similar results. The basal
pp59Lyn autophosphorylation in the presence of the mutant
Src docking site peptide F397 was comparable to that for the control
peptide (which is shown) only. Phosphorimages of enolase tyrosine
phosphorylation were quantitatively evaluated as fold stimulation from
four independent experiments (mean ± standard deviation [right
section]) with basal values set at 1 in each case.
|
|
Consequently, we next studied the impact of blockade of the
pp125
FAK-pp59
Lyn interaction on signaling and
metabolic steps downstream of pp59
Lyn. Src docking site
peptide Y397 introduced into isolated rat adipocytes
drastically
reduced tyrosine phosphorylation of IRS-1 in response
to PIG 41 (at
each concentration studied), whereas nonfunctional
Src docking site
peptide F397 and the unrelated peptide had no
significant effect (Fig.
7). The 75 to 90% blockade of IRS-1
tyrosine
phosphorylation was reflected in a 30 to 55% reduction in
glucose
transport activation only, indicating that in isolated rat
adipocytes,
robust glucose transport stimulation requires modest
tyrosine
phosphorylation of IRS-1 only. Taken together, these findings
confirm the involvement of pp125
FAK and pp59
Lyn
in and their direct interaction (via Y397 of pp125
FAK and
SH2 of pp59
Lyn) during PIG signaling.

View larger version (52K):
[in this window]
[in a new window]
|
FIG. 7.
Effect of pp125FAK-Src docking site peptide
on PIG-induced IRS-1 tyrosine phosphorylation and glucose transport.
Isolated rat adipocytes were electroporated with control peptide,
mutant Src docking site peptide F397, or wild-type Src docking site
peptide Y397 (25 µg/ml) and then incubated in the absence or presence
of increasing concentrations of PIG 41. IRS-1 was immunoprecipitated
(IP) with anti-IRS-1 antibody from defatted cell lysates and then
immunoblotted (IB) with antiphosphotyrosine antibody. Phosphorimages of
a typical experiment are shown (upper section). Other portions of the
cells were assayed for 2-deoxyglucose transport. Data from four
independent experiments were quantitatively evaluated as fold
stimulation (mean ± standard deviation), with basal values set at
1 in each case (lower section).
|
|
The sequence of pp125
FAK contains the twin tyrosines 576 and 577, which are localized in the regulatory loop of its kinase
domain
and are phosphorylated by Src-class kinases both in vitro and
in
vivo (
7). Regulatory loop peptide encompassing residues
568 to 582 from the amino acid sequence of human pp125
FAK
introduced into isolated rat adipocytes by electroporation
significantly
reduced PIG-dependent stimulation of tyrosine
phosphorylation
of pp125
FAK (by 65 to 75%) and total IRS-1
(data not shown) as well as IRS-1
coimmunoprecipitated with the
immunoprecipitated pp125
FAK (by 50 to 65%) compared to
that of a mutant control peptide containing
phenylalanines 576 and 577 (Fig.
8). Interestingly, the PIG-induced
association of IRS-1 with pp125
FAK was not affected by the
regulatory loop peptide, as demonstrated
by sequential
immunoprecipitation of pp125
FAK and IRS-1 from stimulated
adipocytes and subsequent immunoblotting
for IRS-1. This suggests
that phosphorylation of pp125
FAK at the twin tyrosines
by pp59
Lyn, which is presumably prevented by
pp125
FAK regulatory loop peptide, is required for maximal
pp125
FAK activation and tyrosine phosphorylation of IRS-1,
but not for
the interaction of pp125
FAK with IRS-1.

View larger version (63K):
[in this window]
[in a new window]
|
FIG. 8.
Effect of pp125FAK regulatory loop peptide
on PIG-induced tyrosine phosphorylation of pp125FAK and
associated IRS-1. Isolated rat adipocytes were electroporated with
regulatory loop peptide Y576/577 or control peptide F576/577 (50 µg/ml) and then incubated in the absence or presence of increasing
concentrations of PIG 41. pp125FAK was immunoprecipitated
(IP) with anti-pp125FAK antibody from defatted cell lysates
and then either immunoblotted (IB) with antiphosphotyrosine or
anti-pp125FAK antibodies or reimmunoprecipitated with
anti-IRS-1 antibody as indicated. Immunoprecipitated IRS-1 was
immunoblotted with antiphosphotyrosine or anti-IRS-1 antibodies.
Phosphorimages of a typical experiment are shown (left section)
repeated three times with similar results. Quantitative evaluation is
given as fold stimulation (mean ± standard deviation [right
section]). Basal tyrosine phosphorylation is set at 1 in each case.
|
|
The (sequential) arrangement of pp125
FAK,
pp59
Lyn, and IRS-1 in a signaling pathway was further
corroborated by analysis of the
time courses for their tyrosine
phosphorylation in response to
PIG 41 in adipocytes (Fig.
9). PIG stimulation led to rapid
initiation
of tyrosine phosphorylation of pp125
FAK,
subsequently of pp59
Lyn, and finally of IRS-1 in both
isolated rat adipocytes (peaking
at 5 to 30 min), and, with slightly
accelerated kinetics, nonadherent
3T3-L1 adipocytes (peaking at 2 to 15 min). Thereafter, the tyrosine
phosphorylation state of each of these
proteins declined to about
half-maximal values within the following 20 min of incubation,
demonstrating the transient nature of activation of
the pp125
FAK-pp59
Lyn-IRS-1-pathway by PIG in
rat adipocytes and nonadherent 3T3-L1
adipocytes. In adherent 3T3-L1
adipocytes, tyrosine phosphorylation
of pp125
FAK and
pp59
Lyn declined within the initial 2 min of PIG incubation
and then
increased 10-fold within the next 30 min (Fig.
9). However, as
observed with adipocytes in suspension, in adherent 3T3-L1 adipocytes,
PIG-induced tyrosine phosphorylation of IRS-1 followed that of
pp125
FAK and pp59
Lyn with about a 5- to 10-min
delay. Taken together, the time courses
for tyrosine phosphorylation
argue for operation of pp59
Lyn upstream of IRS-1 and
downstream of pp125
FAK within the PIG signaling pathway in
adipocytes.

View larger version (41K):
[in this window]
[in a new window]
|
FIG. 9.
Time course of PIG-induced tyrosine phosphorylation of
pp125FAK, pp59Lyn, and IRS-1. Isolated rat
adipocytes, nonadherent 3T3-L1 adipocytes, and adherent 3T3-L1
adipocytes were stimulated in the presence of 3 µM PIG 41 for various
periods of time. pp125FAK, pp59Lyn, and IRS-1
were immunoprecipitated (IP) with corresponding antibodies from
defatted cell lysates and then immunoblotted (IB) with
antiphosphotyrosine antibody. Phosphorimages of three to five
independent experiments were quantitatively evaluated as
percentages of the control (mean ± standard deviation). Maximal
tyrosine phosphorylation is set at 100% for each time course.
|
|
Integrin engagement in PIG signaling and action in adipocytes.
pp125FAK can be activated by the integrin 
heterodimeric transmembrane cell surface receptors that mediate
interactions between the cell surface and the extracellular matrix
(29, 45). The presence of
1-integrin in rat
adipocytes has been demonstrated previously (14). Therefore,
we studied the effect of clustering of this integrin on IRS-1 tyrosine
phosphorylation by PIG 41.
1-Integrin clustering can be
provoked by incubating cells with activating
anti-
1-integrin monoclonal antibody in the presence of
the extracellular matrix protein fibronectin, which correlates with the
activation of the integrin signaling pathway and enhancement of
tyrosine phosphorylation of certain proteins (e.g.,
pp125FAK) in a variety of cell types (25, 32),
including isolated rat adipocytes (14).
Clustering with activating anti-
1-integrin antibody plus
fibronectin, but not with anti-
3-integrin antibody plus
poly-
L-lysine,
significantly reduced IRS-1 tyrosine
phosphorylation in response
to increasing concentrations of PIG 41 in
comparison to control
incubations (Fig.
10, left section). In nonadherent
3T3-L1 adipocytes
kept in suspension during clustering,
anti-
1-integrin antibody
plus fibronectin diminished
autophosphorylation of pp59
Lyn to 20 to 30% of that in the
absence of clustering (Fig.
10, right
section). In both isolated rat
adipocytes and nonadherent 3T3-L1
adipocytes, this blockade of PIG
signaling by integrin engagement
was completely abolished in the
presence of excess of RGD motif-containing
peptide, GRGDSP, but not of
control peptide, GRADSP (shown for
rat adipocytes, only). This GRGDSP
peptide-mediated restoration
of PIG-induced IRS-1 and
pp59
Lyn tyrosine phosphorylation in the presence of
anti-
1-integrin
antibody plus fibronectin confirms the
specificity of the inhibition
of PIG signaling by integrin engagement
in adipocytes in suspension.

View larger version (61K):
[in this window]
[in a new window]
|
FIG. 10.
Effect of integrin clustering on stimulation of IRS-1
tyrosine phosphorylation by PIG 41. Isolated rat adipocytes or
nonadherent 3T3-L1 adipocytes were treated in the absence or presence
of anti- 1-integrin antibody plus fibronectin or
anti- 3-integrin antibody plus poly-L-lysine
in the absence or presence of 0.5 mM GRGDSP or GRADSP peptide and then
stimulated (5 min) with increasing concentrations of PIG 41. IRS-1 and
pp59Lyn were immunoprecipitated (IP) with corresponding
antibodies from defatted rat adipocyte and 3T3-L1 adipocyte lysates,
respectively, and then immunoblotted (IB) with antiphosphotyrosine
antibody. Phosphorimages from a typical experiment repeated three times
with similar results are shown (left section) or were quantitatively
evaluated from five independent experiments, respectively, as fold
stimulation (mean ± standard deviation [right section]) with
basal values set at 1 in each case.
|
|
Finally, the impact of the apparent antagonism in activation of the
pp125
FAK-pp59
Lyn pathway by integrin engagement
and PIG signaling on PIG-stimulated
glucose transport was studied.
Incubation of isolated rat adipocytes
and nonadherent 3T3-L1 adipocytes
with anti-
1-antibody plus fibronectin,
but not
anti-
3-antibody plus poly-
L-lysine, impaired
2-deoxyglucose
transport stimulation upon challenge with increasing
concentrations
of PIG 41 by up to 50 to 70% in comparison to a control
incubation
(Fig.
11). Strikingly, in
adherent 3T3-L1 adipocytes, PIG-induced
glucose transport activation
was not significantly affected by
1-integrin clustering.

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 11.
Effect of integrin clustering on glucose transport
activation by PIG 41. Isolated rat adipocytes, nonadherent 3T3-L1
adipocytes, or adherent 3T3-L1 adipocytes were treated in the absence
or presence of anti- 1-integrin antibody plus fibronectin
or anti- 3-integrin antibody plus
poly-L-lysine and then incubated in the absence or presence
of increasing concentrations of PIG 41. 2-Deoxyglucose transport was
assayed and quantitatively evaluated from four independent experiments
as fold stimulation (mean ± standard deviation) with basal values
set at 1 in each case.
|
|
 |
DISCUSSION |
In mammals, there is a clear functional distinction between
insulin receptors and other members of the protein tyrosine kinase family. Whereas insulin receptors regulate metabolic pathways
e.g., the translocation of the glucose transporter isoform 4 (GLUT4) from
tubulovesicular structures of the trans-Golgi network to the
plasma membrane in muscle and adipose tissue (9)
all other receptor or non-receptor tyrosine kinases so far identified appear to
control cell growth and differentiation. Consequently, the question
arises of whether this specificity reflects a strict heterogeneity of
the intracellular signaling pathways or whether it is the expression
and the selectivity of the kinases alone that determine cellular
responses (43). If the latter possibility were true, one
would expect that other tyrosine kinases could mimic the metabolic
effects of insulin in cells equipped with an insulin-sensitive GLUT4
translocation apparatus and concomitantly expressing the respective
tyrosine kinase. This assumption has been verified in some cases, but
not in others (17). Many signaling components and processes
are shared by both insulin and growth factors in insulin-sensitive
cells, yet their actions differ. For instance, the PDGF receptor
tyrosine kinase manages to phosphorylate IRS-1 at tyrosine residues in
3T3-L1 adipocytes, which, however, does not correlate with increased
glucose transport (18, 73). There are numerous examples of
positive cross talk from receptors other than the insulin receptor
feeding into the IRS-1-PI 3K pathway, including the G protein-coupled
receptors for angiotensin and endothelin (26, 65, 66, 74);
the cytokine receptors for interferons, interleukins, and tumor
necrosis factor alpha (1, 69, 70, 75); the growth factor
receptors for PDGF and IGF-1 (17, 41, 50); and transmembrane
cell adhesion molecules, such as the integrins (54, 68).
However, only in rare cases have the tyrosine kinases directly feeding
into the IRS-1-PI 3K pathway and their mode of regulation been elucidated.
In the present study, we identified the non-receptor tyrosine kinases,
pp125FAK and pp59Lyn, and
1-integrin as components of the PIG-dependent signaling pathway upstream of IRS-1, which upon direct interaction of the kinases
induces insulin-independent stimulation of glucose transport in
adipocytes. This conclusion is based on the following findings. (i) The
insulin-mimetic metabolic activity of structurally different PIG
compounds correlates well with their ability to induce tyrosine phosphorylation of pp125FAK (Fig. 4), its substrate
paxillin (Fig. 4), and IRS-1 (Fig. 3B), as well as autophosphorylation
of pp59Lyn (Fig. 3A). (ii) Introduction into isolated
adipocytes of antibodies which potently inhibit pp59Lyn
(Fig. 2) and pp125FAK kinase activities (Table 4) as well
as of the functional Src docking site and regulatory loop peptides
derived from pp125FAK (Fig. 7 and 8) drastically impairs
PIG-dependent IRS-1 tyrosine phosphorylation and glucose transport: the
former peptide by direct interference with downstream signaling to
pp59Lyn (Fig. 6), the latter by direct inhibition of full
activation of pp125FAK (Fig. 7). (iii) The time courses for
PIG-dependent activation of pp125FAK and
pp59Lyn are similar in shape to that for tyrosine
phosphorylation of IRS-1, peaking in sequential order (Fig. 8). (iv)
The PIG-dependent tyrosine phosphorylation of pp125FAK and
of pp125FAK-associated IRS-1 is more pronounced in
nonadherent than in adherent 3T3-L1 adipocytes (Fig. 4B and 5). (v)
1-Integrin clustering blocks PIG-dependent
pp59Lyn autophosphorylation, IRS-1 tyrosine
phosphorylation, and glucose transport (Fig. 10 and 11).
These results are compatible with the following model: PIG compounds
trigger activation of pp125FAK, which is antagonized by
integrin engagement. Phosphotyrosine 397 of activated and
autophosphorylated pp125FAK docks to the SH2 domain of
pp59Lyn, which is thereby activated. pp59Lyn
phosphorylates pp125FAK at the tyrosines 576 and 577 within
its regulatory loop, which is a prerequisite for tyrosine
phosphorylation of IRS-1 associated with pp125FAK. Thus,
pp125FAK may act as a common signaling platform for
pp59Lyn and IRS-1, from which the metabolic signal (e.g.,
to the glucose transport system) originates.
Apparently the mechanisms for pp125FAK activation operating
during cell adhesion-integrin clustering and PIG action differ
fundamentally. The inhibition of PIG signaling in response to
simultaneous integrin engagement may be explained by some
conformational or allosteric interference at pp125FAK
directly or at components located upstream, including the integrins. Integrins interact with extracellular matrix proteins, such as fibronectin and vitronectin. So far we have not obtained any
experimental evidence for binding of a radiolabeled PIG derivative to
recombinant
1-integrin in vitro by using either a
binding assay or immunoprecipitation with
anti-
1-antibody (N. Hanekop and G. Müller,
unpublished data). However, during studies of inactivation and
reconstitution of isolated rat adipocytes for PIG action, we previously
identified an N-ethylmaleimide-, trypsin-, and
salt-sensitive component in the plasma membrane, which is required for
PIG-induced tyrosine phosphorylation of IRS-1 and glucose transport
activation (40). This 115-kDa polypeptide specifically
interacts with PIG 41 (M. Gerl, M. Quint, and G. Müller,
unpublished data) and presumably acts as a PIG receptor which may
transmit the PIG signal across the plasma membrane or along the cell
surface to
1-integrin by a mechanism which we are
currently investigating (37, 38). This molecular mode of PIG
action differs strikingly from the classical view of transport of
PIG-like molecules across the plasma membrane into the cytosol, where
they act as allosteric activators or inhibitors of insulin-regulated
enzymes of glucose metabolism (21). We were unable to
measure specific uptake of a radiolabeled PIG derivative into isolated
rat adipocytes (C. Piossek and G. Müller, unpublished data),
arguing against a direct intracellular site of PIG action.
Cell adhesion, as well as PIG action, leads to tyrosine phosphorylation
of IRS-1 to almost the full insulin response in both isolated rat
adipocytes and nonadherent 3T3-L1 adipocytes (14; this study). However, only PIG molecules activate glucose transport to
up to 90% of the maximal insulin effect (12), whereas
direct integrin clustering has no effect (14). This raises
the question of how specificity is determined during PIG, insulin, and
integrin signaling in adipocytes. Certainly, integrin engagement per se is not sufficient for glucose transport activation in
insulin-responsive cells. The desired specificity may be based on (i)
additional input(s) from a different signaling cascade which emerges
from the putative PIG receptor and bypasses IRS-1 and PI 3K or (ii) different modes or kinetics of targeting or activation of IRS-1 and PI
3K. The involvement of (at least) two signals for glucose transport
activation in adipocytes, one derived from the IRS-1-PI 3K pathway,
and the other one unknown so far, is reminiscent of insulin action. It
has been argued that insulin might differentially activate specific
intracellular pools of (various isoforms of) PI 3K (41, 49).
Interestingly, a cell-permeable derivative of
phosphatidylinositol(3,4,5)trisphosphate, a lipid signaling product of PI 3K, was shown to stimulate glucose uptake in 3T3-L1 adipocytes treated with insulin together with the PI 3K inhibitor wortmannin, but to have no effect alone, confirming that PI 3K activation is required but not sufficient for insulin signaling to the
glucose transport system (19). The insulin-mediated
dissociation of the recently discovered Synip protein from VAMP2 and
Syntaxin 4, the v- and t-SNAREs of the GLUT4 translocation apparatus,
which thereby allows VAMP2-Syntaxin 4 interaction and final fusion of GLUT4 vesicles with the plasma membrane, may represent the PI 3K-independent signal for glucose transport activation (31). A recent report with 3T3-L1 adipocytes and L6 myotubes provided further
evidence that insulin stimulates two independent signals contributing
to stimulation of glucose transport with PI 3K leading to plasma
membrane insertion of GLUT4 without stimulating glucose transport and a
PI 3K-independent pathway involving p38 mitogen-activated protein
kinase, which leads to activation of GLUT4 recruited at the cell
surface (61). Apparently PIG signaling fuels both the PI
3K-dependent and PI 3K-independent pathways. Specificity may be
achieved by (i) differential expression of the putative PIG receptor
and/or its downstream signaling components in adipose or muscle versus
non-insulin-responsive tissues and (ii) different time courses and
sites for tyrosine phosphorylation of IRS proteins. The residues
phosphorylated on IRS-1 in response to integrin clustering and PIG
action in adipocytes have not been identified so far. Interestingly, in
vitro phosphorylation of recombinant IRS-1 with pp60Fyn
revealed a unique cohort of phosphotyrosine residues in comparison to
the insulin receptor (60), arguing for differential
phosphorylation of IRS-1 by non-receptor tyrosine kinases.
The physiological relevance of insulin-mimetic PIG signaling in
adipocytes remains a matter of speculation so far. Adipocytes do not
harbor focal adhesions (55), but they clearly express pp125FAK and some other components of integrin signaling,
including pp59Lyn (rat adipocytes) and its homolog
pp60Fyn (3T3-L1 adipocytes). Thus, the role of these
kinases and their regulation by the PIG signaling cascade may be
different in terminally differentiated insulin-responsive cells
compared to in dividing cells. The PIG signaling cascade constituted by
the PIG receptor,
1-integrin (as a negative regulator),
pp125FAK, pp59Lyn, and IRS-1 apparently
operates as a positive cross talk to metabolic insulin signaling. We
speculate that GPI proteins or PIG molecules derived thereby by
lipolytic cleavage in response to certain physiological stimuli, as
demonstrated recently in rat adipocytes upon insulin and glucose
challenge (33), act as natural ligands for the PIG receptor.
These ligands may monitor environmental situations reflecting some
aspect or parameter of cell adhesion or migration (such as coordination
between proliferation and differentiation and metabolic activity)
different from that signaled by the extracellular matrix-integrin interaction.
 |
ACKNOWLEDGMENTS |
We are indebted to Jochen Bauer and Andrea Bauer (Aventis Pharma
Deutschland GmbH, Frankfurt am Main, Germany) for valuable support
during synthesis of the PIG compounds.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Aventis Pharma
Deutschland GmbH, DG Metabolic Diseases, Bldg. H825, 65926 Frankfurt am Main, Germany. Phone: 4969-305-4271. Fax: 4969-305-81767. E-mail: Guenter.Mueller{at}aventis.com.
 |
REFERENCES |
| 1.
|
Argetsinger, L. S.,
G. W. Hsu,
M. G. Myers,
N. Billestrup,
M. F. White, and C. Carter-Su.
1995.
Growth hormone, interferon- , and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1.
J. Biol. Chem.
270:14685-14692[Abstract/Free Full Text].
|
| 2.
|
Ashkenas, J.,
C. H. Damsky,
M. J. Bissell, and Z. Werb.
1994.
Integrins, signaling and the remodeling of the extracellular matrix, p. 79-109.
In
D. A. Cheresh, and R. P. Mecham (ed.), Integrins molecular and biological response to the extracellular matrix. Academic Press, San Diego, Calif.
|
| 3.
|
Baron, V.,
V. Calleja,
P. Ferrari,
F. Alengrin, and E. Van Obberghen.
1998.
pp125FAK focal adhesion kinase is a substrate for the insulin and insulin-like growth factor-I tyrosine kinase receptors.
J. Biol. Chem.
273:7162-7166[Abstract/Free Full Text].
|
| 4.
|
Bellis, S. L.,
J. T. Miller, and C. E. Turner.
1995.
Characterization of tyrosine phosphorylation of paxillin in vitro by focal adhesion kinase.
J. Biol. Chem.
270:17437-17441[Abstract/Free Full Text].
|
| 5.
|
Brown, D. A.
1993.
The tyrosine kinase connection: how GPI-anchored proteins activate T cells.
Curr. Opin. Immunol.
5:349-354[CrossRef][Medline].
|
| 6.
|
Burridge, K.,
C. E. Turner, and L. H. Romer.
1992.
Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly.
J. Cell Biol.
119:893-903[Abstract/Free Full Text].
|
| 7.
|
Calalb, M. B.,
T. R. Polte, and S. K. Hanks.
1995.
Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases.
Mol. Cell. Biol.
15:954-963[Abstract].
|
| 8.
|
Clark, E. A., and J. S. Brugge.
1995.
Integrins and signal transduction pathways: the road taken.
Science
268:233-239[Abstract/Free Full Text].
|
| 9.
|
Czech, M. P., and S. Corvera.
1999.
Signaling mechanisms that regulate glucose transport.
J. Biol. Chem.
274:1865-1868[Free Full Text].
|
| 10.
|
Eide, B. L.,
C. W. Turck, and J. A. Escobedo.
1995.
Identification of Tyr-397 as the primary site of tyrosine phosphorylation and pp60src association in the focal adhesion kinase, pp125FAK.
Mol. Cell. Biol.
15:2819-2827[Abstract].
|
| 11.
|
Frick, W.,
A. Bauer,
J. Bauer,
S. Wied, and G. Müller.
1998.
Insulin-mimetic signalling of synthetic phosphoinositolglycans in isolated rat adipocytes.
Biochem. J.
336:163-181.
|
| 12.
|
Frick, W.,
A. Bauer,
J. Bauer,
S. Wied, and G. Müller.
1998.
Structure-activity relationship of synthetic phosphoinositolglycans mimicking metabolic insulin action.
Biochemistry
37:13421-13436[CrossRef][Medline].
|
| 13.
|
Guan, J. L., and D. Shalloway.
1992.
Regulation of focal adhesion-associated protein tyrosine kinase by both cellular adhesion and oncogenic transformation.
Nature
358:690-692[CrossRef][Medline].
|
| 14.
|
Guilherme, A., and M. P. Czech.
1998.
Stimulation of IRS-1-associated phosphatidylinositol 3-kinase and Akt/protein kinase B but not glucose transport by 1-integrin signaling in rat adipocytes.
J. Biol. Chem.
273:33119-33122[Abstract/Free Full Text].
|
| 15.
|
Guilherme, A.,
K. Torres, and M. P. Czech.
1998.
Cross-talk between insulin receptor and integrin 5 1 signaling pathways.
J. Biol. Chem.
273:22899-22903[Abstract/Free Full Text].
|
| 16.
|
Gustafson, T. A.,
S. A. Moodie, and B. E. Lavan.
1998.
The insulin receptor and metabolic signaling.
Rev. Physiol. Biochem. Pharmacol.
137:71-192.
|
| 17.
|
Huppertz, C.,
C. Schwartz,
W. Becker,
F. Horn,
P. C. Heinrich, and H.-G. Joost.
1996.
Comparison of the effects of insulin, PDGF, interleukin-6, and interferon- on glucose transport in 3T3-L1 cells: lack of cross-talk between tyrosine kinase receptors and JAK/STAT pathways.
Diabetologia
39:1432-1439[CrossRef][Medline].
|
| 18.
|
Isakoff, S. J.,
C. Taha,
E. Rose,
J. Marcussohn,
A. Klip, and E. Y. Skolnik.
1995.
The inability of phosphatidylinositol 3-kinase activation to stimulate GLUT4 translocation indicates additional signaling pathways are required for insulin-stimulated glucose uptake.
Proc. Natl. Acad. Sci. USA
92:10247-10251[Abstract/Free Full Text].
|
| 19.
|
Jiang, T.,
G. Sweeney,
M. T. Rudolf,
A. Klip,
A. Traynor-Kaplan, and R. Y. Tsien.
1998.
Membrane-permeant esters of phosphatidylinositol 3,4,5-triphosphate.
J. Biol. Chem.
273:11017-11024[Abstract/Free Full Text].
|
| 20.
|
Jones, D. R., and I. Varela-Nieto.
1998.
The role of glycosyl-phosphatidylinositol in signal transduction.
Int. J. Biochem. Cell Biol.
30:313-326[CrossRef][Medline].
|
| 21.
|
Jones, D. R., and I. Varela-Nieto.
1999.
Diabetes and the role of inositol-containing lipids in insulin signaling.
Mol. Med.
5:505-514[Medline].
|
| 22.
|
Kessler, A.,
G. Müller,
S. Wied,
A. Crecelius, and J. Eckel.
1998.
Signalling pathways of an insulin-mimetic phosphoinositolglycan-peptide in muscle and adipose tissues.
Biochem. J.
330:277-286.
|
| 23.
|
Knight, J. B.,
K. Yamauchi, and J. E. Pessin.
1995.
Divergent insulin and platelet-derived growth factor regulation of focal adhesion kinase (pp125FAK) tyrosine phosphorylation, and rearrangement of actin stress fibers.
J. Biol. Chem.
270:10199-10203[Abstract/Free Full Text].
|
| 24.
|
Konstantopoulos, N., and S. Clark.
1996.
Insulin and insulin-like growth factor-1 stimulate dephosphorylation of paxillin in parallel with focal adhesion kinase.
Biochem. J.
314:387-390.
|
| 25.
|
Kornberg, L.,
H. S. Earp,
T. J. Parsons,
M. Schaller, and R. L. Juliano.
1992.
Cell adhesion or integrin clustering increases phosphorylation of a focal adhesion-associated tyrosine kinase.
J. Biol. Chem.
267:23439-23442[Abstract/Free Full Text].
|
| 26.
|
Kowalski-Chauvel, A.,
L. Pradayrol,
N. Vaysse, and C. Seva.
1996.
Gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.
J. Biol. Chem.
271:26356-26361[Abstract/Free Full Text].
|
| 27.
|
Lebrun, P.,
I. Mothe-Satney,
L. Delahaye,
E. Van Obberghen, and V. Baron.
1998.
Insulin receptor substrate-1 as a signaling molecule for focal adhesion kinase pp125FAK and pp60src.
J. Biol. Chem.
273:32244-32253[Abstract/Free Full Text].
|
| 28.
|
Le Marchand-Brustel, Y.,
J.-F. Tanti,
M. Cormont,
J.-M. Ricort,
T. Gremeaux, and S. Grillo.
1999.
From insulin receptor signalling to GLUT4 translocation abnormalities in obesity and insulin resistance.
J. Recept. Signal Transduct. Res.
19:217-228[Medline].
|
| 29.
|
Longhurst, C. M., and L. K. Jennings.
1998.
Integrin-mediated signal transduction.
Cell. Mol. Life Sci.
54:514-526[CrossRef][Medline].
|
| 30.
|
Macaulay, S. L., and R. G. Larkins.
1990.
Phospholipase C mimics insulin action on pyruvate dehydrogenase and insulin mediator generation but not glucose transport or utilization.
Cell. Signal.
2:9-19[CrossRef][Medline].
|
| 31.
|
Min, J.,
S. Okada,
M. Kanzaki,
J. S. Elmendorf,
K. J. Coker,
B. P. Ceresa,
L.-J. Syu,
Y. Noda,
A. R. Saltiel, and J. E. Pessin.
1999.
Synip: a novel insulin-regulated Syntaxin 4-binding protein mediating GLUT4 translocation in adipocytes.
Mol. Cell
3:751-760[CrossRef][Medline].
|
| 32.
|
Miyamoto, S.,
H. Teramoto,
J. S. Gutkind, and K. M. Yamada.
1996.
Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: roles of integrin aggregation and occupancy of receptors.
J. Cell Biol.
132:1633-1642.
|
| 33.
|
Müller, G.,
E.-A. Dearey,
A. Korndörfer, and W. Bandlow.
1994.
Stimulation of a glycosyl phosphatidylinositol-specific phospholipase by insulin and the sulfonylurea, glimepiride, in rat adipocytes depends on increased glucose transport.
J. Cell Biol.
126:1267-1276[Abstract/Free Full Text].
|
| 34.
|
Müller, G., and W. Frick.
1999.
Signalling via caveolin: involvement in the cross-talk between phosphoinositolglycans and insulin.
Cell. Mol. Life Sci.
56:945-970[CrossRef][Medline].
|
| 35.
|
Müller, G., and K. Geisen.
1996.
Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at adipocytes.
Horm. Metab. Res.
28:469-487[Medline].
|
| 36.
|
Müller, G.,
K. Schubert,
F. Fiedler, and W. Bandlow.
1992.
The cAMP-binding ectoprotein from Saccharomyces cerevisiae is membrane-anchored by glycosylphosphatidylinositol.
J. Biol. Chem.
267:25337-25346[Abstract/Free Full Text].
|
| 37.
|
Müller, G.,
S. Welte,
A. Bauer, and W. Frick.
1999.
Interaction of caveolin and non-receptor tyrosine kinases as target for insulin-mimetic compounds.
Diabetes
48(Suppl. 1):A219-A220. (Abstract.)
|
| 38.
|
Müller, G.,
S. Welte,
S. Wied,
C. Jung, and W. Frick.
1999.
Involvement of pp125FAK in the insulin-mimetic signaling of phosphoinositol-glycan compounds in adherent/non-adherent adipocytes.
Diabetologia
42(Suppl. 1):A66. (Abstract.)
|
| 39.
|
Müller, G.,
S. Wied,
A. Crecelius,
A. Kessler, and J. Eckel.
1997.
Phosphoinositolglycan-peptides from yeast potently induce metabolic insulin actions in isolated rat adipocytes, cardiomyocytes, and diaphragms.
Endocrinology
138:3459-3475[Abstract/Free Full Text].
|
| 40.
|
Müller, G.,
S. Wied,
C. Piossek,
A. Bauer,
J. Bauer, and W. Frick.
1998.
Convergence and divergence of the signaling pathways for insulin and phosphoinositolglycans.
Mol. Med.
4:299-323[Medline].
|
| 41.
|
Nave, B. T.,
R. J. Haigh,
A. C. Hayward,
K. Siddle, and P. R. Shepherd.
1996.
Compartment-specific regulation of phosphatidylinositol 3-kinase by platelet-derived growth factor and insulin in 3T3-L1 adipocytes.
Biochem. J.
318:55-60.
|
| 42.
|
Nosjean, O.,
A. Briolay, and B. Roux.
1997.
Mammalian GPI proteins: sorting, membrane residence and functions.
Biochim. Biophys. Acta
1331:153-186[Medline].
|
| 43.
|
Nystrom, F. H., and M. J. Quon.
1999.
Insulin signalling: metabolic pathways and mechanisms for specificity.
Cell. Signal.
11:563-574[CrossRef][Medline].
|
| 44.
|
Ouwens, D. M.,
H. M. M. Mikkers,
G. C. M. Van Der Zon,
M. Stein-Gerlach,
A. Ullrich, and J. A. Maassen.
1996.
Insulin-induced tyrosine dephosphorylation of paxillin and focal adhesion kinase requires active phosphotyrosine phosphatase 1D.
Biochem. J.
318:609-614.
|
| 45.
|
Parsons, J. T.
1996.
Integrin-mediated signalling: regulation by protein tyrosine kinases and small GTP-binding proteins.
Curr. Opin. Cell Biol.
8:146-152[CrossRef][Medline].
|
| 46.
|
Quon, M. J.,
M. J. Zarnowski,
M. Guerre-Millo,
M. de la Luz Sierra,
S. I. Taylor, and S. W. Cushman.
1993.
Transfection of DNA into isolated rat adipose cells by electroporation.
Biochem. Biophys. Res. Commun.
194:338-346[CrossRef][Medline].
|
| 47.
|
Resh, M. D.
1998.
Fyn, a Src family tyrosine kinase.
Int. J. Biochem. Cell Biol.
30:1159-1162[CrossRef][Medline].
|
| 48.
|
Richardson, A., and J. T. Parsons.
1995.
Signal transduction through integrins: a central role for focal adhesion kinase?
Bioessays
17:229-236[CrossRef][Medline].
|
| 49.
|
Ricort, J. M.,
J. F. Tanti,
E. Van Obberghen, and Y. Le Marchand-Brustel.
1996.
Differential effects of insulin and platelet-derived growth factor on phosphatidylinositol 3-kinase at the subcellular level in 3T3-L1 adipocytes.
Eur. J. Biochem.
239:17-22[Medline].
|
| 50.
|
Ricort, J. M.,
J. F. Tanti,
E. Van Obberghen, and Y. Le Marchand-Brustel.
1997.
Cross-talk between the platelet-derived growth factor and the insulin signaling pathways in 3T3-L1 adipocytes.
J. Biol. Chem.
272:19814-19818[Abstract/Free Full Text].
|
| 51.
|
Sargiacomo, M.,
M. Sudol,
Z. L. Tang, and M. P. Lisanti.
1993.
Signal transducing molecules and glycosyl-phosphatidylinositol-linked proteins form a caveolin-rich insoluble complex in MDCK cells.
J. Cell Biol.
122:789-807[Abstract/Free Full Text].
|
| 52.
|
Schaller, M. D.,
J. D. Hildebrand,
J. D. Shannon,
J. W. Fox,
R. R. Vines, and J. T. Parsons.
1994.
Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src.
Mol. Cell. Biol.
14:1680-1688[Abstract/Free Full Text].
|
| 53.
|
Schaller, M. D., and J. T. Parsons.
1995.
pp125FAK-dependent tyrosine phosphorylation of paxillin creates a high-affinity binding site for Crk.
Mol. Cell. Biol.
15:2635-2645[Abstract].
|
| 54.
|
Schneller, M.,
K. Vuori, and E. Ruoslahti.
1997.
Alphavbeta3 integrin associates with activated insulin and PDGFbeta receptors and potentiates the biological activity of PDGF.
EMBO J.
16:5600-5607[CrossRef][Medline].
|
| 55.
|
Schwartz, M. A.,
M. D. Schaller, and M. H. Ginsberg.
1995.
Integrins: emerging paradigms of signal transduction.
Annu. Rev. Cell. Dev. Biol.
11:549-599[CrossRef][Medline].
|
| 56.
|
Shenoy-Scaria, A. M.,
L. K. Timson Gauen,
J. Kwong,
A. S. Shaw, and D. M. Lublin.
1993.
Palmitoylation of an amino-terminal cysteine motif of protein kinases p56lck and p59fyn mediates interaction with glycosyl-phosphatidylinositol-anchored proteins.
Mol. Cell. Biol.
13:6385-6392[Abstract/Free Full Text].
|
| 57.
|
Shibata, H.,
F. W. Robinson,
C. F. Benzing, and T. Kono.
1991.
Evidence that protein kinase C may not be involved in the insulin action on cAMP phosphodiesterase: studies with electroporated rat adipocytes that were highly responsive to insulin.
Arch. Biochem. Biophys.
285:97-104[CrossRef][Medline].
|
| 58.
|
Stefanova, I.,
V. Horejsi,
I. J. Ansotegui,
W. Knapp, and H. Stockinger.
1991.
GPI-anchored cell-surface molecules complexed to protein tyrosine kinases.
Science
254:1016-1019[Abstract/Free Full Text].
|
| 59.
|
Su, B.,
G. L. Waneck,
R. A. Flavell, and A. L. M. Bothwell.
1991.
The glycosyl phosphatidylinositol anchor is critical for Ly-6A/E-mediated T cell activation.
J. Cell Biol.
112:377-384[Abstract/Free Full Text].
|
| 60.
|
Sun, X. J.,
S. Pons,
T. Asano,
M. G. Myers,
E. Glasheen, and M. F. White.
1996.
The Fyn tyrosine kinase binds Irs-1 and forms a distinct signaling complex during insulin stimulation.
J. Biol. Chem.
271:10583-10587[Abstract/Free Full Text].
|
| 61.
|
Sweeney, G.,
R. Somwar,
T. Ramlal,
A. Volchuk,
A. Ueyama, and A. Klip.
1999.
An inhibitor of p38 mitogen-activated protein kinase prevents insulin-stimulated glucose transport but not glucose transporter translocation in 3T3-L1 adipocytes and L6 myotubes.
J. Biol. Chem.
274:10071-10078[Abstract/Free Full Text].
|
| 62.
|
Turner, C. E.
1998.
Molecules in focus: paxillin.
Int. J. Biochem. Biophys.
30:955-959.
|
| 63.
|
Turner, C. E.,
J. R. Glenney, and K. Burridge.
1990.
Paxillin: a new vinculin-binding protein present in focal adhesions.
J. Cell Biol.
111:1059-1068[Abstract/Free Full Text].
|
| 64.
|
Varela-Nieto, I.,
Y. Leon, and H. N. Caro.
1996.
Cell signalling by inositol phosphoglycans from different species.
Comp. Biochem. Physiol.
115B:223-241[CrossRef].
|
| 65.
|
Velloso, I. A.,
F. Folli,
X.-U. Sun,
M. F. White,
M. J. A. Saad, and C. R. Kahn.
1996.
Cross-talk between the insulin and angiotensin signaling systems.
Proc. Natl. Acad. Sci. USA
93:12490-12495[Abstract/Free Full Text].
|
| 66.
|
Verdier, F.,
S. Chretien,
C. Billat,
S. Gisselbrecht,
C. Lacombe, and P. Mayeux.
1997.
Erythropoietin induces the tyrosine phosphorylation of insulin receptor substrate-2.
J. Biol. Chem.
272:26173-26178[Abstract/Free Full Text].
|
| 67.
|
Virkamäki, A.,
K. Ueki, and C. R. Kahn.
1999.
Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance.
J. Clin. Investig.
7:931-943.
|
| 68.
|
Vuori, K., and E. Ruoslahti.
1994.
Association of insulin receptor substrate-1 with integrins.
Science
266:1576-1578[Abstract/Free Full Text].
|
| 69.
|
Wang, L. M.,
A. D. Keegan,
W. Li,
G. E. Lienhard,
S. Pacini,
J. S. Gutkind,
M. G. Myers,
X. Sun,
M. F. White,
S. A. Aaronson,
W. E. Paul, and J. H. Pierce.
1993.
Common elements in interleukin 4 and insulin signaling pathways in factor-dependent hematopoietic cells.
Proc. Natl. Acad. Sci. USA
90:4032-4036[Abstract/Free Full Text].
|
| 70.
|
Welham, M. J.,
L. Learmonth,
H. Bone, and J. W. Schrader.
1995.
Interleukin-13 signal transduction in lymphohemopoietic cells. Similarities and differences in signal transduction with interleukin-4 and insulin.
J. Biol. Chem.
270:12286-12296[Abstract/Free Full Text].
|
| 71.
|
White, M. F.
1998.
The IRS-signalling system: a network of docking proteins that mediate insulin action.
Mol. Cell. Biochem.
182:3-11[CrossRef][Medline].
|
| 72.
|
White, M. F., and C. R. Kahn.
1994.
The insulin signaling system.
J. Biol. Chem.
269:1-4[Free Full Text].
|
| 73.
|
Wiese, R. J.,
C. C. Mastick,
D. F. Lazar, and A. R. Saltiel.
1995.
Activation of mitogen-activated protein kinase and phosphatidylinositol 3'-kinase is not sufficient for the hormonal stimulation of glucose uptake, lipogenesis, or glycogen synthesis in 3T3-L1 adipocytes.
J. Biol. Chem.
270:3442-3446[Abstract/Free Full Text].
|
| 74.
|
Wu-Wong, J. R.,
C. E. Berg,
J. Wang,
W. J. Chiou, and B. Fissel.
1999.
Endothelin stimulates glucose uptake and GLUT4 translocation via activation of endothelin ETA receptor in 3T3-L1 adipocytes.
J. Biol. Chem.
274:8103-8110[Abstract/Free Full Text].
|
| 75.
|
Yenush, L., and M. F. White.
1997.
The IRS-signalling system during insulin and cytokine action.
Bioessays
19:491-500[CrossRef][Medline].
|
| 76.
|
Zachary, I., and E. Rozengurt.
1992.
Focal adhesion kinase (pp125FAK): a point of convergence in the action of neuropeptides, integrins, and oncogenes.
Cell
71:891-894[CrossRef][Medline].
|
Molecular and Cellular Biology, July 2000, p. 4708-4723, Vol. 20, No. 13
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Anderwald, C., Muller, G., Koca, G., Furnsinn, C., Waldhausl, W., Roden, M.
(2002). Short-Term Leptin-Dependent Inhibition of Hepatic Gluconeogenesis Is Mediated by Insulin Receptor Substrate-2. Mol. Endocrinol.
16: 1612-1628
[Abstract]
[Full Text]
-
Muller, G., Jung, C., Wied, S., Welte, S., Jordan, H., Frick, W.
(2001). Redistribution of Glycolipid Raft Domain Components Induces Insulin-Mimetic Signaling in Rat Adipocytes. Mol. Cell. Biol.
21: 4553-4567
[Abstract]
[Full Text]